Carlson v. Bioremedi Therapeutic Systems, Inc.

822 F.3d 194, 100 Fed. R. Serv. 454, 2016 U.S. App. LEXIS 8951, 2016 WL 2865256
CourtCourt of Appeals for the Fifth Circuit
DecidedMay 16, 2016
Docket14-20691
StatusPublished
Cited by94 cases

This text of 822 F.3d 194 (Carlson v. Bioremedi Therapeutic Systems, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Carlson v. Bioremedi Therapeutic Systems, Inc., 822 F.3d 194, 100 Fed. R. Serv. 454, 2016 U.S. App. LEXIS 8951, 2016 WL 2865256 (5th Cir. 2016).

Opinion

LESLIE H. SOUTHWICK, Circuit Judge:

David Carlson suffered severe injuries soon after being treated with the defendants’ product, the ProNeuroLight. He and his wife brought this products liability suit against the defendants. At trial, the defendants’ only witness was a chiropractor who had examined Carlson and had been trained to use the ProNeuroLight. We agree with the Carlsons that the district court erred in allowing that witness to give expert testimony without first making a determination about his qualifications.

We REVERSE and REMAND.

FACTUAL AND PROCEDURAL BACKGROUND

In 2010, David Carlson began to lose nerve sensation in his feet, a diabetic condition known as “peripheral neuropathy.” Carlson visited Dr. Lance Durrett, “a chiropractor and alternative medicine specialist” who had been promoting a new treatment for “diabetic neuropathy.” Dr. Durrett examined Carlson and recommended treatment using the ProNeuro-Light device. The ProNeuroLight uses infrared light “to heat up the area to increase the presence of nitrous oxide, which ... dilates the vessels to allow more circulation to get to the area.” 1 Dr. Durrett did not personally perform Carlson’s ProNeuroLight treatment; it was performed by a staff member in the same treatment facility.

Carlson did not experience complications during treatment, and he was not examined before leaving the treatment facility. Within 48 hours, Carlson discovered ulcers on the bottom of his heels. Carlson’s diabetic podiatrist determined these ulcers were in fact “burn eschar.” Ultimately, Carlson’s podiatrist concluded these burns caused a bone infection that required “over a year of hospitalization culminating in a below the knee amputation on one leg, as well as a heel amputation on the opposite foot.”

The Carlsons brought this suit against both the manufacturer and the distributor of the ProNeuroLight device, respectively Light Emitting Designs, Incorporated and Bioremedi Therapeutic Systems, Incorporated. The Carlsons sought damages on three counts of alleged products liability: *198 (1) design defect; (2) manufacturing defect; 2 and (3) marketing defect, i.e., a failure to warn. Before trial, the Carlsons filed a motion to exclude Dr. Durrett’s medical testimony. The district court denied the motion without explanation. Dr. Durrett was the defendants’ only witness during the five-day trial. The jury returned a unanimous verdict for the defendants. The Carlsons timely appealed, challenging only the admission of Dr. Dur-rett’s expert testimony.

DISCUSSION

The Carlsons contend the district court abused its discretion by allowing Dr. Dur-rett, a chiropractor, to “opine[ ] on medical matters relating to wound care, podiatry, neurology, nephrology and diabetic medicine,” as well as “the temperature necessary to cause a burn injury” and “opinions on the [ProNeuroLight] device itself.” When asked whether the ProNeuroLight caused the injuries to Carlson’s feet, Dr. Durrett testified, “I couldn’t conclude the device did it or did not do it.” Later, though, he stated clearer opinions. He testified that Carlson’s injuries “look[ed] like diabetic ulcers.” When asked to comment on a different witness’s conclusion that the ProNeuroLight did cause Carlson’s injuries, Dr. Durrett stated: “There is not enough data to make that decision.” Dr. Durrett also testified that the ProNeu-roLight could not have caused Carlson’s injuries. Indeed, he stated the device was incapable of causing burns because, by design, it cannot raise surface temperatures by more than two degrees Fahrenheit.

The parties appear to agree the challenged testimony is properly labeled expert testimony, instead of lay opinion testimony. Though the defendants never designated Dr. Durrett as an expert, it is the content of testimony, not a witness’s formal designation as an expert witness, which determines whether Rule 702 applies. See Fed.R.Evid. 702. That rule must be used to assess “any part of a witness’s opinion that rests on scientific, technical, or specialized knowledge.... ” United States v. Cooks, 589 F.3d 173, 180 (5th Cir.2009). The defendants even referred to “Dr. Durrett’s expert opinions” when responding to the Carlsons’ pretrial motion to exclude his medical testimony and then described the legal standards a court must use to qualify a witness for expert testimony. Thus, we assess the challenged testimony under Rule 702.

We also conclude that the Carl-sons preserved their challenge to Dr. Dur-rett’s testimony. Initially, the Carlsons filed a pretrial motion to exclude Dr. Dur-rett’s medical testimony. A “pre-trial objection is sufficient to preserve the error for appellate review.” Mathis v. Exxon Corp., 302 F.3d 448, 459 & n. 16 (5th Cir.2002) (citing the 2000 amendment to Federal Rule of Evidence 103). 3 The Carl-sons’ motion to exclude did not cite Rule 702 or the caselaw for analyzing admissibility of expert opinions, but it sufficiently put before the district court the issue of Dr. Durrett’s qualification to give expert testimony. The motion argued Dr. Dur- *199 rett was not qualified “to provide any manner of expert medical testimony”; for support, the Carlsons cited an out-of-circuit decision considering the proper scope of a chiropractor’s expert testimony. Additionally, the Carlsons preserved the issue by twice objecting at trial when Dr. Durrett began to testify about medical causation. A party need not repeatedly object to preserve an issue where the district court has already denied the initial objection. See Douglas v. Alabama, 380 U.S. 415, 420-23, 85 S.Ct. 1074, 13 L.Ed.2d 934 (1965). 4

Because the issue was preserved for appeal, we review the admission of expert testimony for an abuse of discretion. Bocanegra v. Vicmar Servs., Inc., 320 F.3d 581, 584 (5th Cir.2003). The ruling will be upheld unless it was “manifestly erroneous.” United States v. Valencia, 600 F.3d 389, 423 (5th Cir.2010). If we find an abuse of discretion, we still may affirm unless the ruling “affected the substantial rights of the complaining party.” Nunez v. Allstate Ins. Co., 604 F.3d 840, 844 (5th Cir.2010).

I. Abuse of Discretion

The gatekeeping function identified in Daubert v. Merrell Dow Pharmaceuticals, Inc.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
822 F.3d 194, 100 Fed. R. Serv. 454, 2016 U.S. App. LEXIS 8951, 2016 WL 2865256, Counsel Stack Legal Research, https://law.counselstack.com/opinion/carlson-v-bioremedi-therapeutic-systems-inc-ca5-2016.